极早期治疗HIV后部分免疫激活标志物仍异常
本研究基于流感疫苗应答研究样本,比较ART抑制的HIV感染者与HIV阴性对照的免疫激活标志物。极早期启动ART者多数炎症标志物接近正常,但犬尿氨酸-色氨酸比值仍显著升高(P = .008),可能与持续感染和癌症风险相关。
要点
- 极早期ART可恢复多数炎症标志物至接近正常水平
- 犬尿氨酸-色氨酸比值在极早期ART者中仍显著升高
- 该通路异常可能解释持续增加的结核和癌症风险
核心结论
- 极早期启动ART的HIV感染者多数炎症标志物接近正常,但犬尿氨酸通路仍异常活跃。
研究设计与样本
- 从流感疫苗应答研究中采样ART抑制的HIV感染者与HIV阴性对照,均CMV血清阳性且富集HIV风险因素。
- HIV感染者按ART启动时机分层:感染6个月内启动(极早期)与之后启动,后者再按最低CD4+ T细胞计数分层。
- 经混杂因素调整后比较犬尿氨酸-色氨酸比值、IP-10、sCD14、sCD163、sTNFR2、IL-6和suPAR的组间差异。
主要发现
- 多数参与者(92%)为男性,反映旧金山极早期启动ART者的人口学特征。
- 多数标志物在较晚启动ART者中更高。
- 极早期ART组sTNFR2、IL-6和suPAR接近正常,但犬尿氨酸-色氨酸比值显著高于HIV阴性者(P = .008)。
- sCD14、sCD163和IP-10呈相似趋势。
临床怎么用
- 极早期ART虽改善多数炎症标志物,但仍需关注犬尿氨酸通路异常及相关的感染和癌症风险。
- 犬尿氨酸-色氨酸比值可能作为极早期ART者持续免疫异常的监测指标。
局限性
- 样本以男性为主(92%),结果外推需谨慎。
- 样本来源于流感疫苗应答研究,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite early antiretroviral therapy (ART), ART-suppressed people with human immunodeficiency virus (HIV) (PWH) remain at higher risk for infections and infection-related cancers than the general population. The immunologic pathways that remain abnormal in this setting, potentially contributing to these complications, are unclear. METHODS: ART-suppressed PWH and HIV-negative controls, all cytomegalovirus seropositive and enriched for HIV risk factors, were sampled from an influenza vaccine responsiveness study. PWH were stratified by timing of ART initiation (within 6 months of infection [early ART] vs later) and nadir CD4+ T-cell count among later initiators. Between-group differences in kynurenine-tryptophan (KT) ratio, interferon-inducible protein 10, soluble CD14 and CD163, soluble tumor necrosis factor receptor 2, interleukin 6, and soluble urokinase plasminogen activator receptor were assessed after confounder adjustment. RESULTS: Most participants (92%) were male, reflecting the demographics of early-ART initiators in San Francisco. Most biomarkers were higher among later-ART initiators. Participants in the early-ART group achieved near-normal soluble tumor necrosis factor receptor 2, interleukin 6, and soluble urokinase plasminogen activator receptor levels, but substantially higher KT ratio than those without HIV after confounder adjustment (P = .008). Soluble CD14, soluble CD163, and interferon-inducible protein 10 trended similarly. CONCLUSIONS: While early-ART initiators restore near-normal levels of many inflammatory markers, the kynurenine pathway of tryptophan catabolism remains abnormally high. Because this pathway confers adaptive immune defects and predicts tuberculosis and cancer progression, this it may contribute to persistent risks of these complications in this setting.
引用
- Schnittman SR, Deitchman AN, Beck-Engeser G, et al. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021. PMID: 32915986. doi:10.1093/infdis/jiaa580
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。